ROYAL BANK OF CANADA - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 50 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$321,000
+221.0%
10,804
+93.1%
0.00%
Q2 2023$100,000
+85.2%
5,595
+64.8%
0.00%
Q1 2023$54,000
-57.1%
3,394
-50.7%
0.00%
Q4 2022$126,000
+530.0%
6,890
+584.2%
0.00%
Q3 2022$20,000
+53.8%
1,007
+52.1%
0.00%
Q2 2022$13,000
-80.9%
662
-78.6%
0.00%
Q1 2022$68,000
-75.6%
3,088
-68.6%
0.00%
Q4 2021$279,000
+304.3%
9,823
+199.8%
0.00%
Q3 2021$69,000
+25.5%
3,277
+13.1%
0.00%
Q2 2021$55,000
+103.7%
2,897
+62.2%
0.00%
Q1 2021$27,000
+237.5%
1,786
+215.0%
0.00%
Q4 2020$8,000
+700.0%
567
+1432.4%
0.00%
Q3 2020$1,000
-91.7%
37
-94.9%
0.00%
Q2 2020$12,000
+200.0%
723
+162.0%
0.00%
Q1 2020$4,000
-66.7%
276
-42.7%
0.00%
Q4 2019$12,000
+100.0%
482
+16.1%
0.00%
Q3 2019$6,000
-40.0%
4150.0%0.00%
Q2 2019$10,000
+11.1%
4150.0%0.00%
Q1 2019$9,000
+800.0%
415
+1283.3%
0.00%
Q4 2018$1,000
-88.9%
30
-90.9%
0.00%
Q3 2018$9,0003280.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$76,819,0007.66%
RA Capital Management 1,875,209$42,680,0001.84%
Perceptive Advisors 2,587,953$58,901,0001.66%
EMORY UNIVERSITY 97,035$2,209,0001.55%
New Leaf Venture Partners, L.L.C. 167,700$3,817,0001.05%
Orbimed Advisors 1,914,282$43,569,0000.67%
Opaleye Management Inc. 73,000$1,661,0000.46%
Novo Holdings A/S 135,009$3,073,0000.46%
Virtus ETF Advisers LLC 7,934$181,0000.38%
Eventide Asset Management 384,000$8,740,0000.30%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders